title: The compelling case for anti-CD3 in type 1 diabetes.
authors.affiliation: Diabetes Research Institute, University of Miami, Miami, Florida.
authors.forename: Jay S
authors.initials: JS
authors.lastname: Skyler
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002096:C-Peptide / Q000378:metabolism*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D002096:C-Peptide; C502540:teplizumab